New understandings of inflammation processes in cancer patients could lead to expanded treatment options for some types of ovarian tumours.
Some serious ovarian tumours have been found to modify a protein called “CXCL10”, which encourages white blood cells to attack tumour tissues. The modification suppresses action against cancer cells by the body’s normal immune responses.
Researchers believe the findings will complement existing treatments and will aid the development of new treatments which promote increased immune recognition and destruction of tumour cells.
Read more at Monash University